Activity Levels of Tamoxifen Metabolites at the Estrogen Receptor and the Impact of Genetic Polymorphisms of Phase I and II Enzymes on Their Concentration Levels in Plasma

Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen

(2010) Timothy L. Lash et al.   ACTA ONCOLOGICA

Tamoxifen Metabolite Isomer Separation and Quantification by Liquid Chromatography−Tandem Mass Spectrometry

(2010) Malgorzata Jaremko et al.   ANALYTICAL CHEMISTRY

Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer

(2010) Jennifer Gjerde et al.   BMC CANCER

Aromatase inhibitors alone or in sequence with tamoxifen - Clinical Evaluation of the BIG 1-98 trial

(2010) Catherine M Kelly et al.   EXPERT OPINION ON PHARMACOTHERAPY

Coprescription of Tamoxifen and Medications That Inhibit CYP2D6

(2010) Kostandinos Sideras et al.   JOURNAL OF CLINICAL ONCOLOGY

Significant Effect of Polymorphisms inCYP2D6andABCC2on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

(2010) Kazuma Kiyotani et al.   JOURNAL OF CLINICAL ONCOLOGY

Pharmacogenomics of Tamoxifen Therapy

(2009) H. Brauch et al.   CLINICAL CHEMISTRY